Health-evidence reviewers reverse recommendation on a blood test that detects a biomarker of a common cancer after decades of controversy.
Prostate cancer (cells, artificially coloured) affected 1.5 million people worldwide in 2022.Credit: Dr Gopal Murti/Science Photo Library
Does prostate-cancer screening with the common PSA blood tes⦠[+3589 chars]
Does prostate-cancer screening with the common PSA blood tes⦠[+3589 chars]